National Research Corporation (NRC)

Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop secure communications functionality, and funding of up to $25,000 from the CanExport SMEs program to accelerate product innovation and U.S. market growth.

TWO RIVERS, Wis. , Sept. 29, 2025 /PRNewswire/ -- The U.S. Nuclear Regulatory Commission (NRC) has approved subsequent license renewal for Point Beach Nuclear Plant Units 1 and 2, extending operations through 2050 and 2053, respectively.

Terra Innovatum progresses engagement with U.S. NRC to expedite licensing approval and commercialize its reactors by 2028 Terra Innovatum progresses engagement with U.S. NRC to expedite licensing approval and commercialize its reactors by 2028

LINCOLN, Neb.--(BUSINESS WIRE)-- #EmployeeExperience--NRC Health is proud to welcome South Shore Health as its newest partner in healthcare experience excellence.

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare experience, is pleased to announce the appointment of Shane Harrison as its incoming Executive Vice President and Chief Financial Officer, effective on or about September 25, 2025. Chief Financial Officer Shane Harrison is a seasoned finance leader with more than 25 years of experience spanning corporate finance, investor relations, and strategic tran.

National Research's Q2 adjusted earnings improved year over year on cost control and TRCV gains, but a one-time executive expense weighed on margins.

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2025. CEO Statement Trent S. Green, Chief Executive Officer of NRC Health, commented: “We're encouraged by our second-quarter results, which demonstrate continued momentum across key areas of our business. In my early weeks as CEO, I've been energized by feedback from both current and prospective customers, particularly their enthusiasm for our product portf.

Vancouver, British Columbia--(Newsfile Corp. - July 25, 2025) - Nations Royalty Corp. (TSXV: NRC) (OTCQB: NRYCF) (FSE: Y96) ("Nations Royalty" or the "Company") announces that it has granted stock options to certain directors, officers, employees, and consultants to purchase an aggregate of 1,015,000 common shares of the Company at an exercise price of $0.58 per share, being the volume-weighted average price of the Company's shares on the TSX Venture Exchange ("TSXV") for the 5-day period ending July 24, 2025. The options are exercisable for a period of five (5) years and will vest as follows: one-third (1/3) on the date of grant, one-third (1/3) after 12 months, and the remaining one-third (1/3) after 24 months from the date of grant.

National Research reports a year-over-year decline in Q1 earnings, pressured by rising interest costs, declining revenues, and higher debt levels amid ongoing sales force expansion.

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments. Highlights: Total Recurring Value Contract Value Increases Sequentially Sales Force Expansion Accelerates New Share Repurchase Program Announced Operating Expenses Decline Dividend Declared Overview Michael D. Hays, Chief Executive Officer of NRC Health, commented on the Company's performance and recent developments: “Th.

Safety Evaluation Issued by NRC Confirms Regulatory Acceptance of Fuel Qualification Methodology, Paving the Way for Eventual KRONOS Microreactor Deployment at University of Illinois Urbana-Champaign

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's co.

The CEO of Amazon-owned One Medical, Trent Green, will leave that position to become CEO of National Research Corporation, a publicly traded provider of healthcare solutions doing business as NRC Health. NRC Health announced the move in a Wednesday (March 5) press release, saying Green will join the company June 1.

LOUISVILLE, Ky.--(BUSINESS WIRE)-- #EmployeeExperience--UofL Health selects NRC Health to elevate patient and employee experience across its health system.

LINCOLN, Neb.--(BUSINESS WIRE)-- #BIK--NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the second time in three years. This award once again underscores NRC Health's relentless pursuit of excellence in healthcare experience management through innovation and deep partnerships, in which.